menu
ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

AYTU BIOSCIENCE IN (AYTUW)
0.04 -0.035 (-46.67%)  11-10 12:23
Open: 0 Prev Close: 0.075
High: 0 Low: 0
Volume: 0 Market Cap: 0M
Year High: 0 Year Low: 0
Stock Technical Analysis
Overall       
Targets Six months: 0.0936    One year: 0.1226
Supports Support1: 0.0400   Support2: 0.0333
Resistances Resistance1: 0.0802    Resistance2: 0.1050 
Pivot Point  
Moving Averages MA(5): 0.0495      MA(20):  

MA(100):   0     MA(250):  
MACD MACD(12,26): -10000000000.000  -10000000000    Signal(12,26,9): -10000000000.000  -10000000000
Stochastic Oscillator %K(14,3): -10000000000.000  -10000000000    %D(3): -10000000000.000  -10000000000
RSI RSI(14): -10000000000.000  -10000000000
52-Week High: 0.1050  Low: 0.0400  Change(%): -43
Average Volume(K) 3-Month: -10000000000  10-Days: 7
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is below its mid-term; and below long term moving averages. From the relationship between price and moving averages; we can see that: this stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed Bollinger Bands are 0% narrower than normal.

Stoxline

Stock Chart

Top 100 stocks

Stock News
Aytu BioScience, Inc. Announces $11.5 Million Private Placement
Fri, 11 Aug 2017 22:03:49 GMT

Aytu BioScience, Inc. (Nasdaq: AYTU) to Ring The Nasdaq Stock Market Closing Bell
Thu, 19 Oct 2017 14:15:00 GMT

Aytu BioScience Receives Market Approval from the Australian Therapeutic Goods ...
Tue, 07 Nov 2017 13:06:25 GMT

Aytu BioScience Announces Pricing of $7.5 Million Public Offering of Common ...
Tue, 03 May 2016 00:28:47 GMT

Aytu BioScience Announces Expansion of US Sales Team to Support Increasing ...
Wed, 22 Feb 2017 13:06:33 GMT

Aytu BioScience Presents Clinical Findings for its MiOXSYS® System at 73rd ...
Wed, 01 Nov 2017 12:06:26 GMT

Aytu BioScience to Execute Reverse Stock Split in Anticipation of Uplisting ...
Wed, 22 Jun 2016 12:06:32 GMT

Aytu BioScience Inc (AYTU): Is Healthcare An Attractive Sector Play?
Thu, 09 Nov 2017 17:37:30 GMT

Aytu BioScience Appoints Jonathan Heath McGrael as Vice President of Sales
Wed, 09 Sep 2015 12:00:00 GMT

Aytu BioScience Enters $2 Billion Testosterone Replacement Market with ...
Mon, 25 Apr 2016 11:45:43 GMT